Don’t get too excited about ‘female Viagra’ FDA succumbs to pressure to approve first agent to treat hypoactive sexual desire disorder in women.…
Actinic keratosis gel linked with allergic reactions and shingles Picato gel, used to treat actinic keratosis, has been linked with shingles, severe allergic reactions, eye injuries and skin reactions when used incorrectly, the FDA warns.…
First drug to improve sexual desire in women approved in the United States Addyi (flibanserin), a drug dubbed the ‘female Viagra’, has been approved for the treatment of acquired, generalized hypoactive sexual desire disorder in premenopausal women by the FDA.…
FDA approves opioid Oxycontin for adolescents The US Food and Drug Administration has approved the use of the opioid OxyContin (oxycodone) for children aged 11–16 years whose pain is severe enough to require daily around-the-clock long-term treatment for which alternative options are inadequate.…
Questionable marketing tactics are a major problem with pharma Inappropriate marketing strategies used by the pharmaceutical industry to boost drug sales must stop.…
FDA issues new PML warning for fingolimod The US Food and Drug Administration has issued a new safety warning about cases of a rare brain infection in multiple sclerosis patients taking fingolimod (Gilenya).…
Printed levetiracetam pill approved for use by the FDA The US Food and Drug Administration has given the go-ahead to a 3D printed pill containing the epilepsy drug levetiracetam.…
Drug manufacturers delay reporting serious adverse events Almost one in ten serious and unexpected drug events is not reported to the US Food and Drug Administration within the required timeframe.…
Skin cancer drug sonidegib approved in United States The US Food and Drug Administration has approved sonidegib as a treatment for patients with locally advanced basal cell carcinoma.…
First PCSK9 inhibitors approved in Europe and United States The US Food and Drug Administration has approved alirocumab (Praluent), days after evolocumab (Repatha) became the first PCSK9 inhibitor to be approved in the world.…
